Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
343 Defining and therapeutically targeting a fusion-derived public neoantigen in desmoplastic small round cell tumor using T-cell receptor gene therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.
